Company intelligence / Profile preview

BioReliance

Rockville, Maryland, United Statessigmaaldrich.com ↗

Ownership: Private
Employees: ~700
Development stage: Commercial

Overview

Provides biosafety, analytical development, and manufacturing/testing services supporting biologics, gene therapies, vaccines, and small molecules from pre-clinical through commercial production. No direct clinical results as it does not develop its own drugs.[1][2][3][5]

Modalities: BiologicGene therapy (manufacturing services)Vaccine (manufacturing services)Small molecule (toxicology testing)Monoclonal antibody (testing expertise)Cell therapy-related products and cell banks
Industry: Contract Research Organization

Partnerships

Partners with over 600 pharmaceutical and biotechnology companies globally as clients.[5]

Beyond the preview

Go deeper on BioReliance.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioReliance.

Explore the full profile